This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to issue a Sole Source Award for Research and Development of 10,000 lateral flow devices for pre-clinical and clinical studies to rapidly detect HIV
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Centers for Disease Control and Prevention (CDC) Division of HIV Prevention plans to issue a sole source firm fixed price purchase order to Beacon Scientific INC for the production of 10,000 lateral flow devices. These devices will be utilized in both pre-clinical and clinical studies aimed at assessing their effectiveness in rapidly detecting HIV antiretroviral drug usage at point-of-care facilities. The procurement is categorized under commercial services and will be conducted exclusively with Beacon Scientific, based on their proprietary nanoparticle technology that delivers superior results compared to other manufacturers, making them uniquely qualified to fulfill the contract requirements. This action is governed under FAR 12.102-1 and the NAICS code 541714 for Research and Development in Biotechnology. While this notice serves as an intent to award a sole source contract, the government will still consider any quotations or responses submitted within 15 days of the notice issuance, by June 2, 2026, primarily to determine whether a competitive procurement is warranted. Responses should be directed to the designated contract specialist at the CDC. The contract’s place of performance is San Diego, California, and the CDC Office of Acquisition Services in Atlanta, Georgia, is managing the procurement. Contact persons for this opportunity include Eugene L. Gutierrez Jr. and Liubov Kriel, who can be reached via email or phone for further information. The procurement is set aside as a Total Small Business Set-Aside under FAR 19.5.
General Info
Agency
NAICS
Place of Performance
San Diego, CA, 92121, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
The Centers for Disease Control and Prevention Division of HIV Prevention intends to award a sole source firm fixed price purchase order to Beacon Scientific INC for the manufacture of 10,000 lateral flow devices to be used in pre-clinical and clinical studies evaluating their performance and utility in rapidly detecting HIV antiretroviral usage in point-of-care facilities. This contract action is for commercial services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102-1. NAICS 541714 – Research and Development in Biotechnology (except Nanobiotechnology). Beacon Scientific has proprietary state of the art nanoparticle materials that produce superior results to other LFA design companies making them the only source capable of performing the required work. This notice of intent is not a request for competitive quotations; however, all Quotations/ responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to complete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist at email zvm0@cdc.gov by 06/02/2026.